Codon

AUGUST 10, 2023

Technologies DNA Sequencing →DNA sequencing at 40: past, present and future , by Shendure J. Link DNA Cost and Productivity Data, aka "Carlson Curves" , by Carlson R. Link Next-Generation DNA Sequencing Methods , by Mardis E.R. Link DNA synthesis technologies to close the gene writing gap , by Hoose et al.

DNA 98

DNA Cell Biology Molecular Biology Engineering 98

LifeSciVC

APRIL 26, 2024

Beyond simply backing great science (separating the wheat from the chafe), setting a company up properly is critical, and early choices can get locked into the DNA of the company. Some continue to do so today, unfortunately, but there appears to be less of it happening. Second, great teams of truly experienced leaders are scarce.

DNA 111

DNA Science Marketing Clinical Trials 111

Codon

AUGUST 10, 2023

Technologies DNA Sequencing →DNA sequencing at 40: past, present and future , by Shendure J. Link DNA Cost and Productivity Data, aka "Carlson Curves" , by Carlson R. Link Next-Generation DNA Sequencing Methods , by Mardis E.R. Link DNA synthesis technologies to close the gene writing gap , by Hoose et al.

DNA 52

DNA Cell Biology Engineering Molecular Biology 52

Drug Target Review

JANUARY 8, 2024

Modifications to the epigenome, such as DNA hypermethylation, modify the expression of genes by increasing or decreasing their expression without altering the genes themselves. One way we are doing this at Life Biosciences is through partial epigenetic reprogramming. The epigenome drifts with age, leading to dysregulated gene expression.

Science 145

Science Disease FDA Approval DNA 145

Drug Target Review

OCTOBER 26, 2023

Genome engineering and gene therapies that manipulate DNA sequences in cells have driven a biotechnological revolution over the past decade. Molecular Therapy 20 , 1831-1832 (2012). 1 Adeno-associated virus (AAV) vectors are the leading platform for in vivo gene delivery for the treatment of various human diseases. Ylä-Herttuala S.

Engineering 104

Engineering Virus Therapies Immune Response 104

PLOS: DNA Science

SEPTEMBER 21, 2023

(See Socially Responsible Genetic Research with Descendants of the First Australians from 2012.) What steps should researchers take when attempting to acquire DNA samples from modern descendants? The women were wonderfully down-to-earth, stunned at all the attention since they published their key paper in 2012.

DNA 52

DNA Science Medical Schools Government 52

PLOS: DNA Science

OCTOBER 12, 2023

In the final chapter of my 2012 book The Forever Fix: Gene Therapy and the Boy Who Saved It , I predicted that the technology would soon expand well beyond the rare disease world. million DNA bases. The DMD gene therapy delivers a shortened version of the dystrophin gene, just 4,558 DNA bases. appeared first on DNA Science.

Therapies 69

Therapies Immune Response DNA Virus 69

The Pharma Data

SEPTEMBER 3, 2020

One example of current technology is CRISPR, a biological system for altering DNA discovered in 2012. CRISPR scans the genome looking for the right location, and then uses “molecular scissors” to snip through the faulty DNA. While effective in the lab, the process is less than perfect and can cut out too much DNA.

DNA 52

DNA International Science Government 52

Codon

MARCH 19, 2024

Most cells (excluding T-cells and B cells after V(D)J recombination) in our body contain the same DNA but appear and behave in distinct ways: A neuron looks and acts very differently from a hepatocyte. While DNA is relatively stable , the epigenome is not; it has to orchestrate changes in cell state, cell type, and more.

DNA 59

DNA Small Molecule Regulations Laboratories 59

Drug Target Review

NOVEMBER 6, 2023

At AstraZeneca and beyond we are exploring the use of cell-free DNA (cfDNA) methods to assess minimal residual disease as a possible intermediate endpoint across several disease types. 2012);12(4):237-251. Front Pharmacol. 2018;9:1300. Published 2018 Nov 13. doi:10.3389/fphar.2018.01300 2018.01300 Vanneman M, Dranoff G.

Small Molecule 110

Small Molecule Therapies Treatment Immune Response 110

Codon

MARCH 12, 2023

“The recombinant DNA breakthrough has provided us with a new and powerful approach to the questions that have intrigued and plagued man for centuries. The central dogma is often depicted as DNA→RNA→protein, but it’s much more: A biophysical marvel inside the smallest of vessels. Biology is a Burrito. 6 of 31.

DNA 52

DNA Engineering RNA Therapies 52

The Pharma Data

MARCH 22, 2022

PREVYMIS is fully active against viral populations with substitutions conferring resistance to CMV DNA polymerase inhibitors. These DNA polymerase inhibitors are fully active against viral populations with substitutions conferring resistance to PREVYMIS. PREVYMIS has no activity against other viruses.

Disease 52

Disease Virus DNA Hospitals 52

Drug Target Review

OCTOBER 4, 2023

2 In response, DNA-damaging agents that could target the entire cell cycle received renewed attention as ADC payloads. DNA damaging agent-based antibody-drug conjugates for cancer therapy. While highly effective against proliferating tumour cells, ADCs with antimitotic payloads typically struggled against slower-growing cancer types.

Small Molecule 126

Small Molecule Drugs Immune Response Targeted Protein Degradation 126

Drug Discovery World

OCTOBER 21, 2022

DNA-based dyes, amine-reactive, fixable dyes) as oversaturated staining can falsely lead to over-exclusion of live cells from analysis. . He joined BioLegend in 2012, contributing in multiple roles and is now Director of Strategic Marketing responsible for Product Management, Technical Services, and Scientific Applications. .

Drugs 130

Drugs Research Immune Response Production 130

Agency IQ

OCTOBER 12, 2023

In particular, they discussed the potential for genotoxicity, or the potential to damage human DNA, and developmental neurotoxicity, or the negative effect on the developing human nervous system. These experts concluded that there were real concerns regarding the human health risk of chlorpyrifos and CHP-methyl.

Regulations 40

Regulations Animal Testing Government Production 40

Codon

DECEMBER 17, 2023

Recombinant DNA technologies were invented in the 1970s. CRISPR gene-editing was invented in 2012 and applied to human embryos soon after. Gene-editing methods, polymerase chain reaction, and the first human drug made from engineered microbes all debuted in the 1980s. A first draft of the human genome was completed in 2003.

Engineering 52

Engineering Molecular Biology Doctors DNA 52

Codon

JUNE 26, 2023

DNA sequences are designed on a computer, and it takes a dozen or more clicks to change a single nucleotide. DNA sequences are also checked by hand, so it’s easy to make a mistake. The tool outputs a DNA sequence that encodes all the required enzymes. Anyone who has tried to engineer a cell knows how tedious it can be.

DNA 52

DNA Therapies Engineering Clinical Trials 52

Codon

JUNE 26, 2023

DNA sequences are designed on a computer, and it takes a dozen or more clicks to change a single nucleotide. DNA sequences are also checked by hand, so it’s easy to make a mistake. The tool outputs a DNA sequence that encodes all the required enzymes. Anyone who has tried to engineer a cell knows how tedious it can be.

DNA 52

DNA Therapies Engineering Clinical Trials 52

The Pharma Data

NOVEMBER 22, 2021

Important discoveries have included Francis Crick and James Watson’s DNA advance in 1953, and Professor Sir John Gurdon’s work on stem cells in 2012. Over the once century, roughly 50 Nobel Prize winners in chemistry and physiology or drug have been associated with Cambridge. region in the US, and Gothenburg in Sweden.

Molecular Biology 52

Molecular Biology Laboratories Engineering Hospitals 52

Drug Target Review

AUGUST 9, 2023

The specific proteins found in these aggregates can vary, but approximately 95 percent of ALS patients and 50 percent of FTD patients develop aggregates containing the TDP-43 protein (short for tar DNA binding protein 43). 14 TDP-43 is a DNA and RNA binding protein that regulates the expression and splicing of several target transcripts.

RNA 98

RNA Regulations Disease DNA 98

Agency IQ

MARCH 29, 2024

Between 2012 and 2018, the five-year relative survival rate for patients with MM was 57%. Treatment for this cancer may be lifelong, with patient and disease characteristics guiding the course of treatment.

FDA 40

FDA Clinical Trials Trials Treatment 40

Drug Discovery World

OCTOBER 16, 2023

TrakCel based itself in the UK in 2012 because uniting the technology and life-sciences sectors requires a strong, diverse talent pool to draw from, which the UK offers. The UK, and specifically Wales, has been hugely supportive of life sciences and building a highly collaborative network.

Drugs 189

Drugs Science Therapies Targeted Protein Degradation 189

Codon

MARCH 24, 2024

Water accounts for 70 percent of a bacterium by mass; the other 30 percent includes everything else: proteins, RNA, DNA, lipids, and so on. Experiments around using genetically modified organisms to produce proteins have been taking place since the earliest days of the recombinant DNA revolution.

Engineering 87

Engineering Vaccine Production RNA 87

The Pharma Data

OCTOBER 21, 2020

INSTIs, like cabotegravir, inhibit HIV replication by preventing the viral DNA from integrating into the genetic material of human immune cells (T-cells). Shionogi joined in October 2012. This step is essential in the HIV replication cycle and is also responsible for establishing chronic infection.

Clinical Development 52

Clinical Development Therapies Clinical Trials FDA Approval 52

The Pharma Data

MARCH 31, 2023

INSTIs, like cabotegravir extended-release injectable suspension, inhibit HIV replication by preventing the viral DNA from integrating into the genetic material of human immune cells (T-cells). Shionogi became a ViiV shareholder in October 2012. Cabotegravir LA for PrEP is an integrase strand transfer inhibitor (INSTI).

Licensing 40

Licensing Licensing International Treatment 40

Molecule Blog

OCTOBER 1, 2020

It is now known that specific cellular pathways likely underpin the aging process (Burgess, 2012). The development of a drug therapy that extends life is summarised by much of the ongoing work in senolytics , telomeres, stem cells, mitochondria, DNA damage and repair, and gene editing.

Clinical Trials 52

Clinical Trials Therapies Disease Trials 52

Agency IQ

APRIL 19, 2024

Although therapeutics have contributed to improvements in survival, the five-year relative survival rate for patients with MM was just 57% between 2012 and 2018. Despite the availability of treatments, there is still significant unmet need for patients with MM.

FDA 40

FDA Disease Trials Clinical Trials 40

DrugBank

JUNE 27, 2023

In contrast, non-coding mutations have effects on gene expression, transcript stability, and the physical state of the DNA itself (e.g., 13 , 1–27 (2012). Coding mutations have a more direct effect through direct alteration of a gene product. by altering its accessibility to transcriptional machinery). & Barbadilla, A.

Disease 89

Disease Treatment Drugs DNA 89

New Drug Approvals

JANUARY 9, 2024

May 30; 31(11): 2498-510, 2012). CDK7 also plays a role in transcription and possibly in DNA repair. The trimeric Cak complex CDK7/CyclinH/MATl is also a component of TFIIH, the general transcription/DNA repair factor IIH (Morgan, DO., Mar 23;25(6):839-50. 2007; Ganuza et al., Cancer Res. 8, 3527-3538, 2002).

Production 62

Production DNA RNA Regulations 62

Codon

MARCH 7, 2024

Anopheles stephensi , the primary mosquito vector in Southeast Asia, showed up in Northern Africa in 2012. We have taken the liberty of overlaying our own genome next to theirs, and you can see for yourself that even when DNA insertions and deletions are taken into account, humans and chimpanzees still share 96 percent sequence identity.

Vaccine 52

Vaccine Disease Doctors DNA 52

Agency IQ

MARCH 29, 2024

The EPA is also proposing our response to a petition regarding the continued validity of EPA’s 2012 determination (and September 2017 affirmation) that participation in the Cross State Air Pollution Rule (CSAPR) meets the Regional Haze Rule’s criteria for an alternative to the application of source-specific BART.

Regulations 40

Regulations Compliance Production Government 40